Top

Published in:

01-10-2016 | Review

New insights in diagnosis and treatment for Retinopathy of Prematurity

Authors: Linda A. Cernichiaro-Espinosa, Francisco J. Olguin-Manriquez, Andree Henaine-Berra, Gerardo Garcia-Aguirre, Hugo Quiroz-Mercado, Maria A. Martinez-Castellanos

Published in: International Ophthalmology | Issue 5/2016

Abstract

The purpose of this study was to review current perspectives on diagnosis and treatment of Retinopathy of Prematurity (ROP). We performed a systematic review of how much has been produced in research published online and on print regarding ROP in different settings around the world. Early Treatment for ROP (ETROP) classification is the currently accepted classification of ROP. Fluorescein angiography and spectral domain optical coherence tomography (SD-OCT) may eventually lead to changes in the definition of ROP, and as a consequence, they will serve as a guide for treatment. Intravitreal anti-VEGF therapy has proven to be more effective in terms of lowering recurrence, allowing growth of the peripheral retina, and diminishing the incidence of retinal detachment when proliferative ROP is diagnosed. Whether anti-VEGF plus laser are better than any of these therapies separately remains a subject of discussion. Telemedicine is evolving everyday to allow access to remote areas that do not count with a retina specialist for treatment. A management algorithm is proposed according to our reference center experience. ROP is an evolving subject, with a vulnerable population of study that, once treated with good results, leads to a reduction in visual disability and in consequence, in a lifetime improvement.

International Committee for the Classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123(7):991–999CrossRef

iVue Product Website. http://optovue.somethumb.net/products/ivue/ Accessed 1 October 2015

Klufas MA, Patel SN, Ryan MC et al (2015) Influence of fluorescein angiography on the diagnosis and management of retinopathy of prematurity. Ophthalmology 122(8):1601–1608PubMedPubMedCentralCrossRef

Gschliesser A, Stifter E, Neumayer T et al (2015) Inter-expert and Intra-expert Agreement on the Diagnosis and Treatment of Retinopathy of Prematurity. Am J Ophthalmol 160(3):553e3–560e3CrossRef

Patel SN, Klufas MA, Ryan MC et al (2015) Color fundus photography versus fluorescein angiography in identification of the macular center and zone in retinopathy of prematurity. Am J Ophthalmol 159(5):950e2–957e2CrossRef

Ng EY, Lanigan B, O’Keefe M (2006) Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 43(2):85–90PubMed

Yokoi T, Hiraoka M, Miyamoto M et al (2009) Vascular abnormalities in aggressive posterior retinopathy of prematurity detected by fluorescein angiography. Ophthalmology 116(7):1377–1382PubMedCrossRef

Henaine-Berra A, Garcia-Aguirre G, Quiroz-Mercado H, Martinez-Castellanos MA (2014) Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. J AAPOS 18(2):120–123PubMedCrossRef

Alba-Orozco A, Rodríguez-Quiñones L, Sepúlveda H, Morales-Canton V, Martínez-Castellanos MA. Fluorescein Angiography Differences Between Retinopathy of Prematurity and Retinopathy Induced by Oxygen in Preterm Newborns. ARVO 2014 Anual Meeting Abstracts

10.

Vajzovic L, Hendrickson AE, O’Connell RV, et al. (2012) Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. Am J Ophthalmol. 154(5):779–89 e2

11.

Cernichiaro-Espinosa LA, Garcia-Huerta MM, Giordano VE et al (2014) Comparison of iridocorneal angle in infants with retinopathy of prematurity and healthy infants using spectral domain optical coherence tomography. J AAPOS 18(4):344–346PubMedCrossRef

12.

Vinekar A, Avadhani K, Sivakumar M, et al. (2012) Macular edema in premature infants. Ophthalmology. 119(6):1288-9 e1; author reply 9-90 e1

13.

Vinekar A, Avadhani K, Sivakumar M et al (2011) Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 52(8):5183–5188PubMedCrossRef

14.

Vinekar A, Mangalesh S, Jayadev C et al (2015) Macular edema in Asian Indian premature infants with retinopathy of prematurity: impact on visual acuity and refractive status after 1-year. Indian J Ophthalmol 63(5):432–437PubMedPubMedCentralCrossRef

15.

Wu WC, Shih CP, Wang NK et al (2013) Choroidal thickness in patients with a history of retinopathy of prematurity. JAMA Ophthalmol 131(11):1451–1458PubMedCrossRef

16.

Erol MK, Ozdemir O, Turgut Coban D et al (2014) Macular findings obtained by spectral domain optical coherence tomography in retinopathy of prematurity. J Ophthalmol 2014:468653PubMedPubMedCentralCrossRef

17.

Cryotherapy for Retinopathy of Prematurity Cooperative Group (1988) Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 106(4):471–479CrossRef

18.

Cryotherapy for Retinopathy of Prematurity Cooperative Group (2001) Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 119(8):1110–1118CrossRef

19.

STOP-ROP Multicenter Study Group (2000) Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 105(2):295–310CrossRef

20.

Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder ARs, Light reduction in retinopathy of prematurity (LIGHT-ROP) Cooperative Group (1998) Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 338(22):1572–1576PubMedCrossRef

21.

Good WV, Early Treatment for Retinopathy of Prematurity Cooperative G (2004) Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 102: 233–248; discussion 48-50

22.

Early Treatment For Retinopathy of Prematurity Cooperative Group (2003) Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121(12):1684–1694PubMedCrossRef

23.

Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) Group B-RC. Efficacy of intravitreal bevacizumab for stage 3 + retinopathy of prematurity. N Engl J Med 364(7):603–615PubMedPubMedCentralCrossRef

24.

Pertl L, Steinwender G, Mayer C et al (2015) A systematic review and meta-analysis on the safety of vascular endothelial growth factor (VEGF) inhibitors for the treatment of retinopathy of prematurity. PLoS ONE 10(6):e0129383PubMedPubMedCentralCrossRef

25.

Vinekar A, Jayadev C, Mangalesh S et al (2015) Comparing the outcome of single versus multiple session laser photoablation of flat neovascularization in zone 1 aggressive posterior retinopathy of prematurity: a prospective randomized study. Retina 35(10):2130–2136PubMedCrossRef

26.

Kim J, Kim SJ, Chang YS, Park WS (2014) Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Retina 34(1):77–82PubMedCrossRef

27.

Castellanos MA, Schwartz S, Garcia-Aguirre G, Quiroz-Mercado H (2013) Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 97(7):816–819PubMedCrossRef

28.

Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28(3 Suppl):S19–S25PubMedCrossRef

29.

Salman AG, Said AM (2015) Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity. Ophthalmic Res 53(1):15–20PubMedCrossRef

30.

Hard AL, Hellstrom A (2011) On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment—a review. Acta Paediatr 100(12):1523–1527PubMedPubMedCentralCrossRef

31.

Martinez-Castellanos MA, Domenzain-Afendulis JL, Hernandez-Rojas ML et al (2007) Safety and efficacy of intravitreal Bevacizumab for retinopathy of prematurity. IOVS 48(13):85

32.

Olguin-Manriquez FJ, Martínez-Castellanos MA. Efectividad de la terapia antiangiogénica intravítrea como adyuvante en la retinopatía del prematuro. Paper presentation. PAAO Meeting 2015 Bogotá, Colombia

33.

Martinez-Castellanos MA, Schwartz S, Hernandez-Rojas ML et al (2013) Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up. Retina 33(2):329–338PubMedCrossRef

34.

Wong RK, Hubschman S, Tsui I (2015) Reactivation of retinopathy of prematurity after ranibizumab treatment. Retina 35(4):675–680PubMedCrossRef

35.

Chen SN, Lian I, Hwang YC et al (2015) Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab. Retina 35(4):667–674PubMedCrossRef

36.

37.

Nudleman E, Robinson J, Rao P, Drenser KA, Capone A, Trese MT (2015) Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity. Ophthalmology 122(4):755–759PubMedCrossRef

38.

Lakhanpal RR, Davis GH, Sun RL, Albini TA, Holz ER (2006) Lens clarity after 3-port lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity. Arch Ophthalmol 124(1):20–23PubMedCrossRef

39.

Wu WC, Lai CC, Lin RI et al (2011) Modified 23-gauge vitrectomy system for stage 4 retinopathy of prematurity. Arch Ophthalmol 129(10):1326–1331PubMedCrossRef

40.

Carvounis PE, Poll J, Weikert MP, Wilhelmus K, Lakhanpal RR, Holz ER (2010) Refractive outcomes of lens-sparing vitrectomy for retinopathy of prematurity. Arch Ophthalmol 128(7):843–846PubMedCrossRef

41.

Kychenthal A, Dorta P (2010) Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Retina 30(4 Suppl):S32–S36PubMedCrossRef

42.

Kychenthal A, Dorta P (2008) 25-gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Retina 28(3 Suppl):S65–S68PubMedCrossRef

43.

El Rayes EN, Vinekar A, Capone A Jr (2008) Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity. Retina 28(4):568–572PubMedCrossRef

44.

Wu C, Petersen RA, VanderVeen DK (2006) RetCam imaging for retinopathy of prematurity screening. J AAPOS 10(2):107–111PubMedCrossRef

45.

Vinekar A, Gilbert C, Dogra M et al (2014) The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian J Ophthalmol 62(1):41–49PubMedPubMedCentralCrossRef

46.

Ells AL, Holmes JM, Astle WF et al (2003) Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthalmology 110(11):2113–2117PubMedCrossRef

47.

Chiang MF, Keenan JD, Starren J et al (2006) Accuracy and reliability of remote retinopathy of prematurity diagnosis. Arch Ophthalmol 124(3):322–327PubMedCrossRef

48.

Photographic Screening for Retinopathy of Prematurity Cooperative Group (2008) The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes. Retina 28(3 Suppl):S47–54CrossRef

Title: New insights in diagnosis and treatment for Retinopathy of Prematurity
Authors: Linda A. Cernichiaro-Espinosa
Francisco J. Olguin-Manriquez
Andree Henaine-Berra
Gerardo Garcia-Aguirre
Hugo Quiroz-Mercado
Maria A. Martinez-Castellanos
Publication date: 01-10-2016
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 5/2016
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-016-0177-8

At a glance: The STEP trials

Springer Medicine

New insights in diagnosis and treatment for Retinopathy of Prematurity

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2016

Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification

Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery

Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma

Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series

Comparison of the corneal biomechanical properties, optic nerve head topographic parameters, and retinal nerve fiber layer thickness measurements in diabetic and non-diabetic primary open-angle glaucoma

Effect of topical administration of tramadol on corneal wound healing in rats